RHO and cancer: Despite the mentioned side effects, Rho regulators (GEFs, GAPs, and GDIs) can attract more attention in cancer therapy, mainly due to higher specificity in regulation and signaling, which are necessary for proper Rho GTPase function [191,192,193].